AVASTIN 400MG/16ML INJECTION

AVASTIN 400MG/16ML INJECTION is a recombinant monoclonal antibody that belongs to the immunotherapy class of cancer treatment. It can either be used as monotherapy or in combination with chemotherapy or immunotherapy medications to improve the overall survival rate.

While for women with reproductive potential subjected to AVASTIN 400MG/16ML INJECTION, it is advised to discuss with your doctor regarding the effective birth control methods during the treatment. Also to be continued for a minimum of 6 months after the treatment course completion as this medicine may impair fertility.

AVASTIN 400MG/16ML INJECTION is associated with increased risk of bleeding complications and poor wound healing. Hence it is suggested to avoid planning for surgery and maintain an interval of 28days before or after surgery.

All the side effects that are relatively caused by AVASTIN 400MG/16ML INJECTION occur until the drug concentration stays in the body. It is found that this medicine will be contained in our body for almost 4 months after the final dose.

AVASTIN 400MG/16ML INJECTION is given intravenously through infusion and the amount of drug will be measured based on the patient’s body weight, height and age. The first dose will be administered for 90 minutes and if well tolerated the infusion time can be reduced to 30 minutes.

Inform your physician before starting your treatment with AVASTIN 400MG/16ML INJECTION in case, if you are pregnant or planning for pregnancy as this medicine may cause harm to the unborn baby and interrupt the formation of blood vessels.

Please inform your doctor about all the medications, supplements, or herbal products you are currently taking before starting treatment with AVASTIN 400MG/16ML INJECTION, as interactions may occur.

It is crucial to inform your physician before taking AVASTIN 400MG/16ML INJECTION if you have conditions involving inflammation in the stomach (ulcer, colitis), experience allergic reactions to AVASTIN 400MG/16ML INJECTION or its ingredients, have recently undergone surgery (due to increased bleeding risk), or have diabetes, hypertension, or heart problems.

The active ingredient in AVASTIN 400MG/16ML INJECTION is BEVACIZUMAB.

AVASTIN 400MG/16ML INJECTION works by targeting a specific protein called VEGF, which helps tumours grow blood vessels. By blocking VEGF, the medicine helps slow or stop the growth of cancer.